ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Merus NV

Merus NV (2GH)

41.40
-0.80
(-1.90%)
Closed 10 December 8:00AM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
41.40
Bid
40.80
Offer
42.00
Volume
978
39.60 Day's Range 42.80
21.40 52 Week Range 58.50
Previous Close
42.20
Open
42.80
Last Trade
40
@
41.2
Last Trade Time
Average Volume (3m)
127
Financial Volume
-
VWAP
-

2GH Latest News

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC Studie mit Petosemtamab in Kombination mit Pembrolizumab bei 1L...

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m...

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC Petosemtamab in combination with pembrolizumab in 1L r/m PD-L1 expressing...

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en fonction des données de sécurité et d’efficaci

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en...

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und Wirksamkeitsdaten aus der eNRGy-Studie bekannt

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und...

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-4.6-10464739.624844.22983871DE
4-10.1-19.611650485451.551.539.612544.72627361DE
12-3.8-8.4070796460245.251.539.612747.17167127DE
26-7.6-15.51020408164957.539.615948.54794972DE
5219.488.18181818182258.521.39999917544.36210739DE
15617.673.949579831923.858.51916742.00023485DE
26017.673.949579831923.858.51916742.00023485DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NL8Genesis Ai Corp
0.035 €
(130.26%)
78.41k
C0MCCS Abwicklungs AG
0.30 €
(114.29%)
125.51k
2WOWide Open Agriculture Ltd
0.013 €
(85.71%)
35.39k
1UR1Bee Vectoring Technologies International Inc
0.0075 €
(50.00%)
261.4k
KEHChinese People Holdings Co Ltd
0.0045 €
(50.00%)
22.92k
Y7GBioAge Labs Inc
4.46 €
(-76.53%)
20.69k
4APApollo Minerals Ltd
0.005 €
(-41.18%)
49.2k
HF2Reflex Advanced Materials Corp
0.0136 €
(-38.18%)
11.9k
R1EAEV Resources Ltd
0.001 €
(-37.50%)
230.95k
NJF1Grid Metals Corp
0.016 €
(-37.25%)
2k
AXIAtos SE
0.0027 €
(-3.57%)
926.53M
D7GNel ASA
0.2699 €
(2.82%)
5.14M
3CPXiaomi Corporation
3.91 €
(8.34%)
4.02M
9SBSOL Global Investments Corp
0.28 €
(16.67%)
4M
POQ88 Energy Limited
0.001 €
(-16.67%)
2.87M

Discussion

View Full Feed
fuagf fuagf 3 minutes ago
Mob boss malice: Cheney, Kinzinger speak out after President Elect-Trump’s jail threat for Jan 6. Committee members

"Forever relevant - Has the Jan. 6 committee investigation changed American politics?"

Related:

Flashback: Pam Bondi’s been a punchline du
janetcanada janetcanada 4 minutes ago
👀***Billionaire Warren Buffett’s 5 top tips for making your fortune- "To see them all On Google: ©Provided by Metro

✔️2. 'Opportunities come infrequently. When it rains gold, put out the bucket, not the thimble'©Provided by Metro-
***In investment terms, this means acti
RDAR
Quikshft Quikshft 7 minutes ago
I'll admit I don't spend much time educating myself on these matters, but I wondered why Trump would threaten a 25% tariff so I searched a little bit. How do you get your neighbors to rectify a problem with severe consequences for the US? Well, I guess he got their attention and now we'll see how th
CRTG
TMaga TMaga 8 minutes ago
$10.00 down to $1.40 a share
The middle of Dec. for your ClassB to convert to Class A
Just about all of the HCMC assets were moved to HCWC and your share value massively reduced.
Holman calls this a dividend.
HCMC HCWC
Dodger1 Dodger1 11 minutes ago
All about money and control....Ya Ya Ya.....Power...fight the power...join the power???

Go $AABB
AABB
sony12 sony12 12 minutes ago
Thats right!
GRLT
4u2nv2 4u2nv2 13 minutes ago
I will. Go MCIC!!! Chucky dolls do not scare the true believers in MCIC.
MCIC
devil dog 96 devil dog 96 13 minutes ago
Pickme2 since you seem like you think you understand how the OTC works maybe you can help prove me wrong that ATMH does not have one of the best setups in the OTC right now. I put out a Challenge and not one person can prove me wrong yet. Be the hero and show everyone I'm full of sh*t and ATMH does
ATMH
devil dog 96 devil dog 96 13 minutes ago
Pickme2 since you seem like you think you understand how the OTC works maybe you can help prove me wrong that ATMH does not have one of the best setups in the OTC right now. I put out a Challenge and not one person can prove me wrong yet. Be the hero and show everyone I'm full of sh*t and ATMH does
ATMH
Stock Guy777 Stock Guy777 14 minutes ago
I agree! Let Go!
HMBL
Stock Guy777 Stock Guy777 15 minutes ago
Yes, it certainly was hugely life-changing for many! I too was sick after it hit its first dollar! And thought it can’t possibly go higher can it??….LMAO! Oh well.. we all know the answer to that!

I will not complain. I have been blessed!
Not only pennies.

Let t
HMBL
lodas lodas 16 minutes ago
@ goodietime.....I cannot help you with your questions, simply because you seem to be incapable in accepting what the company has filed in official SEC documents... if you dont believe in what these documents say, then you certainly will not believe in what I post.... I suggest that you call JPM and
JPM
XenaLives XenaLives 16 minutes ago
Riddle me this...

Why would I accept Jack Anderson's accout of alleged "Operation Mockingburg" asset.originally referenced here:

https://gateway.okhistory.org/ark:/67531/metadc2122478/m1/22/

Expose an asset involved with "Operation Mockiingberg"
rickstereo3333 rickstereo3333 16 minutes ago
Reread what you clearly posted....it had nothing to do with the proposed Trials.

My issue isn't you expressing an opinion since that's basically what we all do, but rather its because your opinion about IDE being granted mid 2025 is totally unsubstantiated and just silly.
RDGL
MRJ25 MRJ25 16 minutes ago
Howard says that the twins are already reformed. Don Layton stated the same years ago.
What are "they" waiting for?
They, meaning the senate.
FNMA
MeteoricChimera43 MeteoricChimera43 16 minutes ago
Or just STFU 🤫 😂😂
RVNC
XenaLives XenaLives 17 minutes ago
Yeah, Goodazi in the orange porche means that I was living with an operative...


So that leaves Cipro and Gadolinium. The sure way to get this straightened out would be to see Dr. Gundry in Palm Springs for a full work up. Not an easy thing to do, but when you've tried everyt
actiontime actiontime 17 minutes ago
Right Again!!
Stupid investors!! They missed the move up and it's so easy to fix...
Buy the Dip and Enjoy the Rip!!!
💰💰💰😎
TMaga TMaga 18 minutes ago
The real numbers. Not 72 million. Yes mega R/S over 200,000 to 1
7 more days for your dividend, I mean theft. Almost 4 years in HCMC for $300.00
All of the HCMC assets moved into this POS. Thanks Jeffrey, Bernie or is it Sam

Market Cap: Micro Cap
$11.98M
Sh
HCMC
konshe konshe 18 minutes ago
Sheer nonsense
RDGL
Truthsocial Truthsocial 19 minutes ago
EXACTLY RDGL PARALLEL PARALLEL PARALLEL UNIVERSAL....
RDGL
littlejohn littlejohn 20 minutes ago
SMCI, $44.16 new closing high is bullish

in the latest rally stage of rebounding...

$47 was almost reached intraday in

trading on Monday...only the day matters...

$52 is still next short term price resistance

area to be taken
SMCI

Your Recent History

Delayed Upgrade Clock